The International IVF Initiative - i3

AI Technology to Improve Embryo Selection using Still Images

Dr. Michelle Perugini

AI Technology to Improve Embryo Selection using Still Images
AI Technology to Improve Embryo Selection using Still Images
AI Technology to Improve Embryo Selection using Still Images
Load image into Gallery viewer, AI Technology to Improve Embryo Selection using Still Images
Load image into Gallery viewer, AI Technology to Improve Embryo Selection using Still Images
Load image into Gallery viewer, AI Technology to Improve Embryo Selection using Still Images

AI Technology to Improve Embryo Selection using Still Images

DR. MICHELLE PERUGINI

Dr. Michelle Perugini

Dr. Michelle Perugini is an academic and entrepreneur with extensive experience in health and medical research, and advanced AI technologies. Dr Perugini has a PhD in Medicine and spent over a decade as a stem cell biologist specialising in predictive genetics and translational medicine. In 2007, Dr Perugini Co-Founded a global technology company, ISD Analytics, using AI to predict human behaviour of whole populations to assist with strategic and social policy planning. ISD was acquired by Ernst and Young {EY) in 2015.

Dr Perugini is now the Co-Founder and CEO of Presagen, an AI company that connects clinics globally to build scalable AI medical products. Presagen’s first product is Life Whisperer, a web-based application that uses AI to assist clinicians with embryo selection during the IVF process to improve pregnancy success rates and shorten the time to pregnancy for patients. Life Whisperer is commercially available globally. The company now has a global clinical collaborative project open for its second AI product for non-invasive embryo assessment during IVF.

Close (esc)

Email List

Stay up to date with the latest sessions and news from I3.

Sign Up

Age verification

By clicking enter you are verifying that you are old enough to consume alcohol.

Search

Shopping Cart

Your cart is currently empty.
Shop now